Gene-Based Therapeutics for Parkinson’s Disease
<div><p>Parkinson’s disease (PD) is a complex multifactorial disorder that is not yet fully surmised, and it is only when such a disease is tackled on multiple levels simultaneously that we should expect to see fruitful results. Gene therapy is a modern medical practice that theoreticall...
محفوظ في:
| المؤلف الرئيسي: | Karim E. Shalaby (12267224) (author) |
|---|---|
| مؤلفون آخرون: | Omar M. A. El-Agnaf (8809331) (author) |
| منشور في: |
2022
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Mitochondrial dysfunction: A notable contributor to the progression of Alzheimer's and Parkinson's disease
حسب: Abolaji Samson Olagunju (16855185)
منشور في: (2023) -
Tissue-Specific Delivery of CRISPR Therapeutics: Strategies and Mechanisms of Non-Viral Vectors
حسب: Karim Shalaby (18718678)
منشور في: (2020) -
Parkinson’s disease and schizophrenia interactomes contain temporally distinct gene clusters underlying comorbid mechanisms and unique disease processes
حسب: Kalyani B. Karunakaran (12478431)
منشور في: (2024) -
Fibrillar form of α-synuclein-specific scFv antibody inhibits α-synuclein seeds induced aggregation and toxicity
حسب: Vijay Gupta (209146)
منشور في: (2020) -
Author Correction: Parkinson’s disease and schizophrenia interactomes contain temporally distinct gene clusters underlying comorbid mechanisms and unique disease processes
حسب: Kalyani B. Karunakaran (12478431)
منشور في: (2024)